Literature DB >> 19655409

In vitro activity of Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori.

Yuan-Chuen Wang1, Deng-Chang Wu, Jyun-Ji Liao, Cheng-Hsun Wu, Wan-Yu Li, Bi-Chuang Weng.   

Abstract

Impatiens balsamina L. has been used as indigenous medicine in Asia for the treatment of rheumatism, fractures, and fingernail inflammation. In this study, anti-H. pylori activity of I. balsamina L. was investigated. The MICs, MBCs, time-kill assay, and effect of environmental pH for the plant extracts were determined. The test H. pylori strains have resistance to clarithromycin (CLR), metronidazole (MTZ), and levofloxacin (LVX). From our results, all part (root/stem/leaf, seed, and pod) extracts of I. balsamina L. exhibited bactericidal H. pylori activity. Specifically, the pod extract had significantly lower MICs and MBCs (1.25-2.5 and 1.25-5.0 microg/ml, respectively). Of the five pod-extraction solvents, both ethyl acetate and acetone were the most efficient for the anti-H. pylori compounds of the pod extraction. The dose-dependency of the pod extract's bactericidal activity was H. pylori strain-dependent. Bactericidal H. pylori activity of the pod extract was not affected by the environmental pH (2-8). In summary, the acetone and ethyl acetate pod extracts of I. balsamina L. exhibited very strong anti-H. pylori activity. This activity exceeded that of MTZ and approximated to that of AMX.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655409     DOI: 10.1142/S0192415X09007181

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

Review 1.  Medicinal plant activity on Helicobacter pylori related diseases.

Authors:  Yuan-Chuen Wang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

2.  Adverse Effects of Hydroalcoholic Extracts and the Major Components in the Stems of Impatiens balsamina L. on Caenorhabditis elegans.

Authors:  Hong-Fang Jiang; Zi-Heng Zhuang; Bei-Wei Hou; Bao-Jun Shi; Cheng-Jie Shu; Lei Chen; Guo-Xin Shi; Wei-Ming Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-23       Impact factor: 2.629

3.  In Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pylori.

Authors:  Yuan-Chuen Wang; Wan-Yu Li; Deng-Chyang Wu; Jeh-Jeng Wang; Cheng-Hsun Wu; Jyun-Ji Liao; Cheng-Kun Lin
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

Review 4.  Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.

Authors:  Paula Roszczenko-Jasińska; Marta Ilona Wojtyś; Elżbieta K Jagusztyn-Krynicka
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-14       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.